Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  8, 943 - 949 (2002)
Published online: 5 August 2002; | doi:10.1038/nm752

SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts

Sunao Takeshita1, 6, Noriyuki Namba1, 2, 6, Jenny J. Zhao3, Yebin Jiang3, Harry K. Genant3, Matthew J. Silva4, Michael D. Brodt4, Cheryl D. Helgason5, Janet Kalesnikoff5, Michael J. Rauh5, R. Keith Humphries5, Gerald Krystal5, Steven L. Teitelbaum1 & F. Patrick Ross1

1  Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA

2  Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan

3  Osteoporosis and Arthritis Research Group, Department of Radiology, University of California, San Francisco, USA

4  Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA

5  Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada

6  S.T. and N.N. contributed equally to this study.

Correspondence should be addressed to F. Patrick Ross rossf@medicine.wustl.edu
The hematopoietic-restricted protein Src homology 2−containing inositol-5-phosphatase (SHIP) blunts phosphatidylinositol-3-kinase-initiated signaling by dephosphorylating its major substrate, phosphatidylinositol-3,4,5-trisphosphate. As SHIP-/- mice contain increased numbers of osteoclast precursors, that is, macrophages, we examined bones from these animals and found that osteoclast number is increased two-fold. This increased number is due to the prolonged life span of these cells and to hypersensitivity of precursors to macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappaB ligand (RANKL). Similar to pagetic osteoclasts, SHIP-/- osteoclasts are enlarged, containing upwards of 100 nuclei, and exhibit enhanced resorptive activity. Moreover, as in Paget disease, serum levels of interleukin-6 are markedly increased in SHIP-/- mice. Consistent with accelerated resorptive activity, 3D trabecular volume fraction, trabecular thickness, number and connectivity density of SHIP-/- long bones are reduced, resulting in a 22% loss of bone-mineral density and a 49% decrease in fracture energy. Thus, SHIP negatively regulates osteoclast formation and function and the absence of this enzyme results in severe osteoporosis.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Comparative Skeletal Structure
Nature Encyclopaedia of Life Sciences

REVIEWS
Genetic regulation of osteoclast development and function
Nature Reviews Genetics Review (01 Aug 2003)
 See all 3 matches for Reviews

RESEARCH
Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim
The EMBO Journal Article (15 Dec 2003)
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta
Nature Letters to Editor (18 Apr 2002)
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
Nature Letters to Editor (15 Apr 2004)
 See all 12 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link
Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy